It plans to introduce its own brands in the latter part of the year. The technology works faster than nature can with a process that is considerably less resource-intensive and more reliable than growing plants, flowers or trees, Debut claims.ĭebut’s Joshua Britton in the lab / Credit: Billy Economou of BE Studios and Ariba Alvi of Debutĭebut claims it is the only biotech player with full vertical integration capabilities incorporating ingredient discovery, clinically backed scalable ingredients and brands on shelf. In layman’s terms, the company’s scientists, thanks to genome research, have developed a method of studying how plants make molecules in nature, then replicating the process at scale using enzymes - for example sugar - in its laboratories. Its intellectual property portfolio includes more than 7,000 ingredients that can be created without the need for living cells, and the company claims it can take an ingredient like a polyphenol from discovery to delivery in as little as six weeks.
According to L’Oréal’s deputy chief executive officer in charge of research, innovation and technology Barbara Lavernos, Debut “addresses one of the beauty world’s fundamental challenges, which is driving limitless, open innovation without the resource-intensity and environmental impact that comes with relying on traditional manufacturing alone.”ĭebut, founded four years ago, specializes in the vertically integrated discovery, development, testing and manufacturing of novel ingredients, and claims to now be ready to produce these for the beauty market at scale.
0 kommentar(er)
